EICHOR
● Active Not Recruiting
A Study to Investigate Weight Management With LY3841136 and Tirzepatide (LY3298176), Alone or in Combination, in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Condition: Obesity · Overweight · Sponsor: Eli Lilly and Company
About this study
The main purpose of this study, performed under the master protocol W8M-MC-CWMM (NCT06143956), is to investigate the safety and efficacy of LY3841136 for chronic weight management alone or in combination with Tirzepatide across a wide dose range in participants with Type 2 Diabetes. Participation in the study will last about 64 weeks.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (52)
| The Institute for Liver Health II dba Arizona Clinical Trials - Mesa | Chandler, Arizona, United States | — |
| HOPE Research Institute | Phoenix, Arizona, United States | — |
| Headlands Research - Scottsdale | Scottsdale, Arizona, United States | — |
| The Institute for Liver Health II dba Arizona Liver Health-Tucson | Tucson, Arizona, United States | — |
| NorCal Medical Research, Inc | Greenbrae, California, United States | — |
| Velocity Clinical Research, Huntington Park | Huntington Park, California, United States | — |
| Peninsula Research Associates | Rolling Hills Estates, California, United States | — |
| Diablo Clinical Research, Inc. | Walnut Creek, California, United States | — |
| Stamford Therapeutics Consortium | Stamford, Connecticut, United States | — |
| Northeast Research Institute (NERI) | Fleming Island, Florida, United States | — |
| Indago Research & Health Center, Inc | Hialeah, Florida, United States | — |
| New Horizon Research Center | Miami, Florida, United States | — |
+ 40 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06603571